The Joint Corp. (JYNT) Business Model Canvas

The Joint Corp. (JYNT): Business Model Canvas [Dec-2025 Updated]

US | Healthcare | Medical - Care Facilities | NASDAQ
The Joint Corp. (JYNT) Business Model Canvas

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

The Joint Corp. (JYNT) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

As a seasoned analyst, you're looking past the noise to see how The Joint Corp. is truly making money now that they are pushing hard to be a pure-play franchisor, and the numbers from late 2025 tell a clear story. With 92% of their 962 total clinics now franchised, the business model is clearly shifting to an asset-light structure, prioritizing predictable royalty fees-like the $8.1 million collected in Q2 2025-over corporate clinic operations. This strategic pivot, centered on their value proposition of convenient, cash-based pain relief, is the core of their current valuation thesis, so check out the full nine-block breakdown below to map out their operational engine.

The Joint Corp. (JYNT) - Canvas Business Model: Key Partnerships

You're looking at the structure that lets The Joint Corp. scale without owning every location, which is the core of their asset-light strategy. These relationships are critical for market penetration and capital management, so let's look at the hard numbers defining these alliances as of late 2025.

The relationship with multi-unit franchisees is central, especially with major operators like Joint Ventures, LLC. This franchisee acquired 31 corporate clinics in Arizona and New Mexico, bringing their total operating count to 96 clinics across California, Oregon, New Mexico, and Arizona as of the June 2025 agreement. Furthermore, Joint Ventures committed to opening another 10 clinics in that region. This transaction was valued at $8.3 million in cash plus the acquisition of Regional Developer rights.

The overall network scale as of September 30, 2025, shows 962 total clinics, with 884 of those being franchised, highlighting the reliance on external operators. The Joint Corp. is actively managing this network through Regional Developers (RDs).

The role of Regional Developers is to manage territory expansion, a function The Joint Corp. is consolidating. For instance, the Northwest regional developer rights acquired from Joint Ventures covered 46 existing franchised clinics and 30 sites earmarked for future development. These specific RD rights generated $855,000 in royalties and franchise fees for the trailing twelve months ended March 31, 2025. As of Q1 2025, 16 regional developers were active, covering approximately 56% of the network, with 46 franchise licenses in active development under their purview.

Financially, the partnership with JP Morgan Chase is key for liquidity. The Joint Corp. maintains a currently undrawn line of credit with JP Morgan Chase, N.A., which grants immediate access to $20 million; this facility's maturity date was extended to August 31, 2027, following a third amendment on September 30, 2025.

Here's a quick look at the scale of the key franchisee and developer relationships:

  • Joint Ventures, LLC clinic count: 96 clinics.
  • Northwest RD rights royalty/fee generation (TTM ended 3/31/2025): $855,000.
  • Total clinics as of September 30, 2025: 962.
  • Franchised clinics as of September 30, 2025: 884.
  • Active Regional Developers (Q1 2025): 16.

The local operational backbone relies on the independent chiropractors and clinic staff. While specific staffing numbers aren't always broken out, the sheer volume of the network dictates the scale of this partnership requirement. The system-wide sales for the quarter ended September 30, 2025, reached $127.3 million.

The financial backing and the franchise structure can be summarized like this:

Partner Type Specific Entity/Role Key Metric/Amount (Late 2025 Data)
Multi-Unit Franchisee Joint Ventures, LLC (Clinic Count) 96 Clinics
Financial Institution JP Morgan Chase Line of Credit Access $20 million
Regional Developer Network Active RDs (Q1 2025) 16
Total Network Scale Total Clinics (9/30/2025) 962
Franchise Operations Franchised Clinics (9/30/2025) 884

The company is definitely moving toward a pure-play franchisor model, which shifts more operational risk and capital expenditure to these partners.

The Joint Corp. (JYNT) - Canvas Business Model: Key Activities

You're looking at the core actions The Joint Corp. (JYNT) is taking to reshape its business into a leaner, franchise-focused entity as of late 2025. This isn't just about opening and closing doors; it's a fundamental shift in asset ownership and brand positioning.

Franchising and refranchising corporate clinics to an asset-light model

The primary activity here is shedding corporate-owned clinics to become what management calls a 'pure-play franchisor.' This reduces capital intensity and shifts the revenue mix toward more predictable royalty streams. As of September 30, 2025, the portfolio stood at 962 total clinics, with 884 of those being franchised, meaning 92% of the network is now franchisee-owned. This is a major move from the 125 company-owned clinics at the end of 2024.

The pace of this transition was significant in 2025. In the second quarter alone, The Joint Corp. (JYNT) refranchised 37 clinics, bringing in $11.2 million. By the third quarter, they refranchised one more clinic and sold eight new franchise licenses. To complete the asset-light goal, an initial agreement was signed to sell 45 corporate clinics in Southern California for $4.5 million. Management is also actively negotiating asset purchase agreements for the remaining corporate clinics, which numbered 78 as of September 30, 2025. The company recorded a $7.7 million gain from clinic sales in the first six months of 2025.

Here's a snapshot of the clinic portfolio evolution:

Metric Q2 2025 (June 30) Q3 2025 (Sept 30)
Total Clinics 967 962
Franchised Clinics 885 884
Company-Owned Clinics 82 78
Franchised Percentage 92% 92%

The full-year 2025 guidance for new franchised clinic openings remains in the range of 30 to 35. That's the plan for getting to that pure-play status.

Developing proprietary software and the new patient-facing mobile app

Investing in technology supports both the franchise network and the patient experience. The development of internal systems, including the new patient-facing mobile app, is reflected in the financial statements. In the third quarter of 2025, depreciation and amortization expenses rose by $100,000, specifically citing software development related to the new mobile app launch. For the first nine months of 2025, IT cost of revenues totaled $1,271,700. This tech investment is intended to enrich the patient experience and extend their lifetime value, per management commentary from Q2 2025.

Providing centralized franchise support, training, and operational standards

Supporting the growing franchise base is a key activity that ensures brand consistency and performance. The Joint Corp. (JYNT) sold eight franchise licenses in Q3 2025, up from seven in Q3 2024. At the end of Q3 2025, there were 149 franchise licenses already sold but still in active development. To help these new clinics start strong, the operations team implemented robust preopening protocols. This focus is designed to reduce the time it takes for a new clinic to reach its breakeven point.

Centralized support also involves evolving the leadership structure to better manage the brand's direction. The company welcomed Debbie L. Gonzalez as Chief Marketing Officer in October 2025, highlighting her background in recurring revenue membership models and digital initiatives.

  • Sold 8 franchise licenses in Q3 2025.
  • Had 149 franchise licenses in active development as of September 30, 2025.
  • Implemented robust preopening protocols for new clinics.

Executing the digital marketing transformation and brand pivot to pain relief

The brand pivot is a deliberate move away from general wellness toward a more targeted focus on pain relief, which requires significant marketing execution. Selling and marketing expenses in Q3 2025 were $2.8 million, representing a 13% increase year-over-year, driven mainly by these transformation efforts. For the first nine months of 2025, selling and marketing expenses totaled $9,805,075.

The transformation involves amplifying the pain relief message by shifting advertising spend from local to national campaigns. Furthermore, digital efforts are being strengthened through investments in search engine optimization (SEO) and more impactful clinic microsites to improve website rankings. To test pricing under the new focus, The Joint Corp. (JYNT) initiated a three-tiered pricing pilot for its wellness plan in November 2025.

The results of the operational headwinds are visible in the guidance revision, even as revenue grew 6% to $13.4 million in Q3 2025. Full-year 2025 system-wide sales guidance was revised down to a range of $530 million to $534 million, and comparable sales are now expected to be between (1)% and 0%. Finance: draft 13-week cash view by Friday.

The Joint Corp. (JYNT) - Canvas Business Model: Key Resources

You're looking at the core assets The Joint Corp. (JYNT) relies on to run and grow its business model right now. These aren't just abstract concepts; they are measurable components of their current operational strength.

The brand equity is significant, built on being the largest franchisor of chiropractic clinics in the US. This recognition translates into tangible marketing advantages and franchisee appeal. The Joint Chiropractic is consistently named to Franchise Times' annual "Top 400" and "Fast & Serious" list of 40 smartest growing brands. Entrepreneur named The Joint "No. 1 in Chiropractic Services," and it is regularly ranked on the publication's "Franchise 500," the "Fastest-Growing Franchises," the "Best of the Best" lists, as well as its "Top Franchise for Veterans" and "Top Brands for Multi-Unit Owners." SUCCESS named the company as one of the "Top 50 Franchises" in 2024.

The national retail footprint is defined by the scale of the network, which is actively being streamlined toward a pure-play franchisor model. As of September 30, 2025, the total clinic count stood at 962 locations. This network is heavily weighted toward the franchise side of the business, which is a key strategic shift.

Here's the quick math on the clinic network as of the end of Q3 2025:

Metric Amount
Total Clinics 962
Franchised Clinics 884
Company-Owned or Managed Clinics 78
Percentage Franchised 92%

Liquidity remains a core resource for funding operations and strategic initiatives like stock repurchases. As of September 30, 2025, The Joint Corp. reported unrestricted cash and cash equivalents of $29.7 million. They also maintain a currently undrawn line of credit with JP Morgan Chase, which grants immediate access to $20 million through August 2027.

Technology underpins the patient experience and operational efficiency. While the search results point to various industry software, The Joint Corp. (JYNT) is actively investing in its own digital assets. For instance, in the third quarter of 2025, depreciation and amortization increased by $100,000, mainly due to software development for their new mobile app, which launched systemwide in July 2025.

The technological assets include systems that support the retail healthcare model:

  • Proprietary systems managing patient data and clinic operations.
  • A new mobile app launched in July 2025 for patient convenience.
  • Features in the app like geofencing for in-clinic check-in.
  • The ability to send push notifications for promotions and news.

If onboarding new franchisees takes longer than expected, the utilization of these standardized systems will be crucial for maintaining brand consistency across the 884 franchised locations.

The Joint Corp. (JYNT) - Canvas Business Model: Value Propositions

You're looking at the core reasons why The Joint Corp. (JYNT) has scaled to become the nation's largest franchisor of chiropractic clinics. The value propositions are built around removing the traditional barriers to routine care: time, complexity, and cost.

Convenient, no-appointment, walk-in chiropractic care.

The Joint Corp. (JYNT) emphasizes accessibility, which is reflected in its sheer scale and operational model. As of September 30, 2025, the network comprised 962 total clinics, with 884 being franchised locations. This vast footprint supports a high-volume model, having handled 14.7 million patient visits in 2024 alone. The model is explicitly designed around convenience:

  • No appointments are required for service.
  • Hours accommodate evenings and weekends.
  • The environment is standardized and approachable, like a retail setting.

Affordable, cash-based model eliminating the need for insurance.

This is perhaps the most disruptive element of the value proposition. By focusing on cash and membership, The Joint Corp. (JYNT) bypasses the administrative friction of insurance, which is a major pain point for patients seeking routine care. The financial structure makes regular visits highly competitive against typical insurance co-pays.

Here's a quick look at the pricing structure as of 2025 data:

Service Type Price Point / Range Notes
Initial Visit Offer Valued at $55 Includes consultation, exam, and adjustment.
Single Visit (Post-Initial) $55 For those preferring to pay as they go.
Wellness Plan (Up to 4 visits/month) Per Visit Cost: $18 to $23 Best for patients visiting two or more times per month.
Package Visits (e.g., 20 Visits) Cost per visit: As low as $22 Flexible options for 1-2 visits per month.

The reliance on this model is clear: in 2024, 85% of system-wide gross sales came from memberships. Also, 36% of new patients in 2024 had never visited a chiropractor before The Joint, suggesting the affordability proposition is attracting a new customer segment.

Focused pain relief message, shifting from general wellness.

While the model supports routine wellness, the primary draw is targeted relief. The company is making quality care accessible for millions of patients seeking pain relief and ongoing wellness. The CEO noted a strategic focus on driving new patient acquisition, which is critical for a model reliant on recurring visits. The goal is to make routine care accessible to more people.

Standardized, non-clinical, and approachable retail clinic environment.

The physical layout and service delivery are designed to feel less like a traditional medical office and more like a convenient retail service. This is supported by the low initial buildout cost for franchisees compared to other health and wellness concepts like gyms or saunas. The company is the clear category leader, being larger than its next 10 competitors combined at the end of 2024. The focus on a simplified experience-no insurance hassles, no waiting for approvals-is central to this retail approach.

Finance: review Q4 2025 cash flow projections against the $29.7 million unrestricted cash balance as of September 30, 2025.

The Joint Corp. (JYNT) - Canvas Business Model: Customer Relationships

You're looking at how The Joint Corp. (JYNT) keeps its patients coming back and supports the people running the clinics. The focus here is on locking in that recurring revenue and making the patient journey smoother, especially as they push to be a pure-play franchisor.

Membership and wellness plans for recurring revenue and patient retention

The membership model is the backbone of The Joint Corp.'s revenue engine. This structure is designed to drive patient retention through predictable, recurring payments rather than one-off visits. You saw this clearly in 2024, where 85% of system-wide gross sales came directly from these memberships. This recurring revenue stream is what makes the asset-light model so attractive to franchisees.

To keep enhancing this, The Joint Corp. is actively testing ways to optimize pricing and value. As of November 2025, the company initiated a three-tiered pricing pilot specifically for its wellness plan. The strategy involves continuing to implement nominal price increases to balance affordability with the perceived patient value. This focus on membership underpins their goal of extending patient lifetime value (LTV).

Here's a snapshot of the revenue structure and related operational scale:

Metric Value (2024 Full Year) Value (Q3 2025)
System-Wide Sales $530.3 million $127.3 million
Percentage of Sales from Memberships 85% Not explicitly stated for Q3 2025, but the model relies on this.
Revenue from Continuing Operations $51.9 million $13.4 million
Comp Sales (Clinics 13+ months) 4% (2.0)%

The comp sales figure for Q3 2025 shows some near-term softness, which is why they're pushing technology and pricing pilots.

Self-service and engagement via the new mobile app

Investing in patient-facing technology is a direct effort to improve the customer relationship through convenience. The new mobile app officially launched systemwide in July 2025, following a multi-phase beta test. This technology investment was significant enough that depreciation and amortization expenses increased by 18% in Q2 2025, partly due to internal use software enhancements like the app launch.

Early adoption showed promise; in the second quarter of 2025, the app achieved approximately 10% active-patient adoption during its early rollout phase. The app is designed to streamline the in-clinic experience with specific features:

  • In-Clinic Check-In using geofencing technology.
  • Clinic Locator for finding the nearest location.
  • Doctor In Clinic view to plan visits around preferred providers.
  • Push Notifications for timely updates and promotions.

The goal is clear: extend LTV and engagement through seamless access to care. That's how you turn a visitor into a member.

High-touch support for franchisees and regional developers

For the franchise network, customer relationship management shifts to high-touch support to ensure consistent brand delivery and growth. The Joint Corp. is aggressively executing its transition to a pure-play franchisor, which requires strong relationships with its multi-unit operators. By the end of Q3 2025, the total clinic count stood at 962, with 884 being franchised, meaning 92% of the portfolio was franchised as of June 30, 2025.

Support is demonstrated through direct transactions and territory acquisition:

  • Refranchised 37 corporate clinics in Q2 2025 for $11.2 million.
  • Sold 13 franchise licenses in Q2 2025 and eight in Q3 2025.
  • Acquired the rights to the Northwest regional developer (RD) territory for $2.8 million in Q2 2025.

The company is actively negotiating asset purchase agreements for all remaining corporate clinics, signaling a final push to complete the pure-play transition by the end of 2025. Finance: draft 13-week cash view by Friday.

The Joint Corp. (JYNT) - Canvas Business Model: Channels

You're looking at how The Joint Corp. (JYNT) gets its services to the customer as of the end of Q3 2025. It's a heavily franchised model now, but the remaining corporate clinics are actively being sold off.

The primary channel remains the physical clinic footprint, which is overwhelmingly franchised.

Channel Type Count as of Q3 2025 (Sept 30, 2025) Portfolio Percentage Recent Activity (Q3 2025)
Franchised Clinics 884 units 92% Opened nine, closed 11
Company-Owned/Managed Clinics 78 units remaining 8% Closed three units
Total System Clinics 962 units 100% Refranchised one clinic

The strategic pivot is clear, moving capital from operations to the balance sheet. For instance, in Q2 2025, The Joint Corp. refranchised 37 clinics for $11.2 million. Also, an initial agreement was signed to sell 45 corporate clinics in Southern California for $4.5 million. This shift reduces the direct operational channel while increasing the royalty-based franchise channel.

Digital and media channels are being refined to drive traffic into these physical locations. The company is actively investing in its digital presence.

  • Selling and marketing expenses for Q3 2025 were reported at $2.8 million.
  • This Q3 2025 spend represented a 13% increase year-over-year, driven by digital marketing transformation efforts.
  • The brand marketing campaign shifted focus to pain relief, amplified by moving advertising spend from local to a national campaign.
  • The mobile app, launched in July 2025, saw 18% adoption among new patients, with approximately 178,000 downloads.
  • New "Kickstart" plans introduced in July 2025 were purchased by approximately 25% of new patients.

The physical retail presence is designed for accessibility, which is key to the value proposition. These are not appointment-only facilities.

The Joint Chiropractic locations are situated in convenient retail settings, often in strip malls, supporting the model of walk-in, affordable care that does not require insurance processing.

Finance: draft Q4 2025 cash flow projection by next Tuesday.

The Joint Corp. (JYNT) - Canvas Business Model: Customer Segments

You're analyzing The Joint Corp. (JYNT) and need to map out exactly who is walking through their clinic doors and who is buying into their system. The customer base clearly splits into two main groups: the end-users of the chiropractic service and the business partners buying the franchise rights.

Mass Market Consumers Seeking Routine, Affordable Chiropractic Adjustments

This segment is the core of The Joint Chiropractic's retail model. They are the people looking for quick, accessible care without the typical friction points of traditional healthcare. The company emphasizes making care convenient and affordable, specifically by eliminating the need for insurance. This appeals directly to a mass market accustomed to retail convenience. In 2024, The Joint Corp. recorded 14.7 million patient visits across its network. Furthermore, a significant portion of their growth comes from bringing new people into the category; in 2024, 36% of new patients had never visited a chiropractor before. This suggests a successful capture of consumers previously outside the traditional chiropractic market. The model's reliance on membership plans, which accounted for 85% of system-wide gross sales in 2024, speaks directly to the routine, recurring nature of this customer segment.

Patients with Acute or Chronic Pain Seeking Relief Without Insurance Hassle

This group seeks relief from pain, whether it's a sudden issue or ongoing chronic discomfort, but they prioritize speed and simplicity over complex billing. The Joint Chiropractic's policy of no appointments and low, transparent pricing directly serves this need for hassle-free relief. The company is actively pivoting its marketing to focus more on pain relief over general wellness, which targets this segment more acutely. For the nine months ended September 30, 2025, the system generated $39.7 million in revenue from continuing operations. While the exact split between acute and chronic pain patients isn't public, the high volume of visits-over 14 million annually-indicates a large base relying on this accessible care pathway. The company's structure, which refers patients with severe health issues to other professionals, reinforces its position as the go-to for non-severe, routine adjustments.

Multi-Unit Operators and Investors Seeking a Service-Based Franchise Model

This segment is composed of entrepreneurs and established multi-unit operators looking for a proven, service-based franchise opportunity. The Joint Corp. is actively transforming into a pure-play franchisor, which makes this segment critical to its future structure. As of September 30, 2025, the clinic portfolio was 92% franchised, totaling 884 franchised clinics out of 962 total locations. This transition is evidenced by Q2 2025 activity where the company sold 13 franchise licenses and refranchised 37 clinics for $11.2 million. The long-term potential for these operators is substantial; The Joint Corp. has identified ideal locations for approximately another 1,000 clinics in the US alone, meaning they are only about 50% of the way to their identified domestic potential. This group is attracted to the asset-light nature of the model as the company sheds corporate-owned clinics.

Here's a quick look at the scale of the system serving these customer segments as of late 2025:

Metric Value as of Q3 2025 (Sept 30, 2025) Context/Period
Total Clinics 962 As of September 30, 2025
Franchised Clinics Percentage 92% As of September 30, 2025
Franchised Clinics Count 884 As of September 30, 2025
Company-Owned Clinics Count 78 As of September 30, 2025
System-Wide Sales $127.3 million Q3 2025
Annual Patient Visits (Latest Reported) 14.7 million 2024
New Patients (Latest Reported) 957,000 2024

The appeal to multi-unit operators is also seen in the recognition they receive from industry bodies. The brand was ranked No. 139 on Franchise Times' Top 400 list in 2025, and Entrepreneur named The Joint the top franchise in chiropractic services earlier in 2025. These accolades help validate the model for potential franchisees.

The consumer base is segmented by their need for care, which dictates their engagement level:

  • Consumers seeking routine, affordable adjustments.
  • Patients needing acute or chronic pain relief.
  • New patients, where 36% in 2024 were new to chiropractic care.
  • Franchise investors seeking a scalable service model.

The company's goal to reach approximately 1,950 potential clinic locations across the US, DC, and Puerto Rico shows the long runway for the franchisee segment. If you're looking at the investor side, the push to become a pure-play franchisor means the primary customer relationship shifts from clinic-level service delivery to managing the royalty stream from these operators. Finance: draft 13-week cash view by Friday.

The Joint Corp. (JYNT) - Canvas Business Model: Cost Structure

You're looking at the expenses The Joint Corp. incurs to run its franchisor and managed clinic operations as of late 2025. This structure is heavily influenced by the ongoing transition to a pure-play franchisor model, which shifts certain operational costs.

General and administrative (G&A) expenses, which were $7.3 million in Q3 2025, showed a slight reduction, decreasing 3% compared to the prior year period, reflecting efforts to right-size the cost structure. This is a key area where management is focusing on operating leverage.

Selling and marketing expenses totaled $2.8 million in Q3 2025. This represented an increase of 13% year-over-year, driven by the digital marketing transformation efforts and shifting ad spend toward national media to amplify the pain management brand message.

The costs associated with supporting the franchise network are significant. Franchise support and regional developer cost of revenues for Q3 2025 were reported at $2.232 million. This figure was actually down 6% compared to the third quarter of 2024, which the company attributed to lower regional developer royalties.

IT and software development costs are embedded within several line items, notably Depreciation and Amortization (D&A), which reflects capitalization of internal-use software. Depreciation and amortization expenses increased 18% in Q2 2025, directly tied to internal use software enhancements and developments, including the launch of the new mobile app. For Q3 2025, D&A was $0.4 million.

Here's a quick look at how these major cost components stacked up for the third quarter of 2025, based on continuing operations:

Cost Category Q3 2025 Amount (Continuing Operations) Year-over-Year Change (Q3 2025 vs Q3 2024)
General and Administrative (G&A) Expenses $7.3 million Decreased 3%
Selling and Marketing Expenses $2.8 million Increased 13%
Franchise and Regional Development Cost of Revenues $2.232 million Cost of Revenue overall decreased 6%
IT Investment Impact (D&A related to software) $402,000 (Q2 2025 D&A) Increased 18% in Q2 2025

You should also note other cost drivers that impact the bottom line as The Joint Corp. continues its strategic shift:

  • Cost of revenue was $2.7 million in Q3 2025, down 6% year-over-year.
  • Income tax expense for Q3 2025 was $10,000.
  • The company repurchased 228,000 shares for $2.3 million in Q3 2025.
  • The company has an undrawn line of credit with JP Morgan Chase for $20 million available through August 2027.

Finance: draft 13-week cash view by Friday.

The Joint Corp. (JYNT) - Canvas Business Model: Revenue Streams

You're looking at how The Joint Corp. (JYPT) pulls in cash, which is heavily weighted toward its franchise network. Honestly, the recurring revenue from those established locations is the bedrock here, but don't overlook the upfront fees and other smaller buckets that add up.

Here's a quick look at the components that made up their reported revenue streams for the second quarter of 2025. We can see the scale of the ongoing royalty machine versus the growth engine of new unit sales.

Revenue Component Q2 2025 Amount
Royalty Fees $8.1 million
Advertising Fund Revenue $2.3 million
Corporate Clinic Revenue & Software Fees $1.5 million
Franchise Fees (New Licenses) (Based on 13 units sold)

The core revenue drivers for The Joint Corp. (JYNT) fall into a few distinct categories, which is typical for a franchisor model. If onboarding takes 14+ days, churn risk rises, so unit growth is key.

  • Royalty fees from franchisees, which hit $8.1 million in Q2 2025.
  • Franchise fees from new license sales, with 13 new clinics sold in Q2 2025.
  • Advertising fund revenue, totaling $2.3 million for the second quarter of 2025.
  • Corporate clinic revenue and associated software fees, amounting to $1.5 million in Q2 2025.

Looking further out, the total economic activity across the entire system gives you a sense of the revenue base The Joint Corp. (JYNT) is collecting royalties on. The full-year 2025 system-wide sales guidance sits between $530 million to $534 million. That's the top line the royalty percentage is applied against, so it's a critical metric for forecasting future royalty income, assuming the average royalty rate stays consistent.

Finance: draft 13-week cash view by Friday, making sure to factor in the defintely higher Q3 franchise fee projections.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.